Encompass Health Corporation (EHC) — Financial statements
Income statement, balance sheet, and cash flow for Encompass Health Corporation — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 5,935↑10.5% | 5,373↑11.9% | 4,801↑10.4% | 4,349↑8.3% | 4,015 | |
| Cost of Revenue | 254↓91.9% | 3,140↑11.4% | 2,818↑8.6% | 2,595↑12.3% | 2,312 | |
| Gross Profit | 5,681↑154.4% | 2,233↑12.6% | 1,983↑13.1% | 1,753↑2.9% | 1,703 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 3,411↑1180.0% | 267↑32.1% | 202↓3.5% | 209↓8.5% | 229 | |
| Selling & Marketing Expenses | 0.00 | 0.00↓100.0% | 56 | 0.00 | 0.00 | |
| SG&A Expenses | 3,411↑1180.0% | 267↑3.3% | 258↑23.4% | 209↓8.5% | 229 | |
| Other Expenses | 1,217↑10.4% | 1,102 | 0.00↓100.0% | 914↑12.1% | 816 | |
| Operating Expenses | 4,628↑238.1% | 1,369↑430.5% | 258↓77.0% | 1,123↑7.6% | 1,044 | |
| Total Costs & Expenses | 4,882↑8.3% | 4,509↑46.6% | 3,076↓17.3% | 3,718↑10.8% | 3,356 | |
| Operating Results | ||||||
| Operating Income | 1,053↑21.8% | 865↓49.9% | 1,725↑173.7% | 630↓4.4% | 659 | |
| Depreciation & Amortization | 328↑9.4% | 300↑9.4% | 274↑12.4% | 244↑10.9% | 220 | |
| EBITDA | 1,404↑18.3% | 1,187↑18.0% | 1,006↑15.6% | 870↓2.1% | 889 | |
| EBIT | 1,076↑21.3% | 887↑21.2% | 732↑16.8% | 627↓6.4% | 669 | |
| Interest & Other Income | ||||||
| Net Interest Income | -123↑10.3% | -137↑4.3% | -144↑18.3% | -176↓6.9% | -164 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 123↓10.3% | 137↓4.3% | 144↓18.3% | 176↑6.9% | 164 | |
| Non-Operating Income | -23↓2.7% | -23↓102.3% | 993↑26737.8% | 4↑137.4% | -10 | |
| Other Income / Expenses | -100↑12.9% | -115↑89.7% | -1,118↓523.0% | -179↓16.2% | -154 | |
| Income Before Tax | 953↑27.1% | 750↑23.5% | 607↑34.7% | 451↓10.7% | 505 | |
| Income Tax Expense | 193↑28.4% | 150↑13.6% | 132↑32.1% | 100↓1.8% | 102 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 760↑26.8% | 599↑26.2% | 475↑35.4% | 351↓13.0% | 403 | |
| Net Income from Discontinued Operations | -1↑64.3% | -3↑76.7% | -12↓178.9% | 15↓86.7% | 114 | |
| Net Income | 566↑24.2% | 456↑29.5% | 352↑29.9% | 271↓34.3% | 412 | |
| Bottom-Line Net Income | 566↑24.2% | 456↑29.5% | 352↑29.9% | 271↓34.3% | 412 | |
| EPS (Basic) | 5.62↑24.1% | 4.53↑28.0% | 3.54↑30.1% | 2.72↓34.5% | 4.15 | |
| EPS (Diluted) | 5.54↑24.2% | 4.46↑28.5% | 3.47↑28.5% | 2.70↓34.3% | 4.11 | |
| Weighted Average Shares | 101↑0.6% | 100↑0.4% | 100↑0.3% | 99↑0.2% | 99 | |
| Weighted Average Diluted Shares | 102↑0.0% | 102↑0.9% | 101↑0.9% | 100↑0.2% | 100 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.